Positive Airway Pressure for the Treatment of OSA in Infants

Abstract

Positive airway pressure (PAP) is a standard therapy for the treatment of OSA in children, but objective data on the effectiveness of PAP in infants are sparse. The aim of this study was to compare the effectiveness of PAP in infants younger than 6months of age with that in school-aged children. Compared with PAP in school-aged children, can PAP be titrated as successfully in infants, and is adherence to PAP similar in both age groups? Single-center retrospective study. For consecutive infants younger than 6months of age and school-aged children 5 to 10 years of age with OSA treated with PAP, baseline and titration polysomnography data, PAP adherence data, and parent-reported barriers to adherence were compared between groups. Forty-one infants and 109 school-aged children were included. Median obstructive apnea hypopnea index (OAHI) in infants was 25.7/h (interquartile range [IQR], 17.8-35.9/h) and was greater than that in school-aged children (12.1/hr; IQR, 7.6-21.5/h; P< .0001). After PAP titration, OAHI was reduced by a median of 92.1%in infants, similar to the median 93.4%reduction in school-aged children (P= .67). PAP was used in infants on 94.7%of nights, which was more than the 83%in school-aged children (P= .003). No differences were found in barriers to adherence between infants and school-aged children, with behavioral barriers being most common in both groups. Objective data demonstrate that PAP is both highly effective at treating OSA and well-tolerated in infants. Like older patients, PAP should be considered along with other therapies for the treatment of OSA in even the youngest children.